Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a... AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. Show more
- Top-line data with unexpected results requiring further clarification, did not meet primary endpoint as per protocol - Potent growth hormone release following macimorelin stimulation - Safety of...
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2 | 5.07614213198 | 3.94 | 4.31 | 3.925 | 5325 | 4.09651418 | CS |
| 4 | -1.51 | -26.7256637168 | 5.65 | 6.4 | 3.49 | 13493 | 4.10229766 | CS |
| 12 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11124 | 4.26479029 | CS |
| 26 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11124 | 4.26479029 | CS |
| 52 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11124 | 4.26479029 | CS |
| 156 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11124 | 4.26479029 | CS |
| 260 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11124 | 4.26479029 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
